Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
idelalisib治疗复发性、利妥昔单抗和烷化剂难治性滤泡性淋巴瘤患者的疗效和安全性：一项II期研究的亚组分析
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2016.151738
Salles, Gilles; Schuster, Stephen J; de Vos, Sven; Wagner-Johnston, Nina D; Viardot, Andreas; Blum, Kristie A; Flowers, Christopher R; Jurczak, Wojciech J; Flinn, Ian W; Kahl, Brad S; Martin, Peter; Kim, Yeonhee; Shreay, Sanatan; Will, Matthias; Sorensen, Bess; Breuleux, Madlaina; Zinzani, Pier Luigi; Gopal, Ajay K
